Announcements Trials
Browse Landscape

Phase

Phase NA 36Phase 2 23Phase 1 8Phase 3 7Phase 2/3 4Phase 1/2 4Phase EARLY_PHASE1 2Phase 4 1

Status

Unknown 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 699Breast Neoplasms 629Neoplasms 582Leukemia, Myeloid, Acute 481Colorectal Neoplasms 455Multiple Myeloma 444Melanoma 424Prostatic Neoplasms 383Neoplasm Metastasis 370Pancreatic Neoplasms 361Recurrence 347Lymphoma 340Ovarian Neoplasms 322Lung Neoplasms 297Lymphoma, Non-Hodgkin 295Leukemia 287Glioblastoma 275Precursor Cell Lymphoblastic Leukemia-Lymphoma 249Stomach Neoplasms 246Leukemia, Lymphocytic, Chronic, B-Cell 235Carcinoma, Hepatocellular 231Squamous Cell Carcinoma of Head and Neck 219Lymphoma, Large B-Cell, Diffuse 217Myelodysplastic Syndromes 212Carcinoma, Renal Cell 210Lymphoma, Follicular 183Head and Neck Neoplasms 172Brain Neoplasms 169Triple Negative Breast Neoplasms 167Lymphoma, Mantle-Cell 167

Interventions

Standard of Care 1Practice Guidelines as Topic 1IBIO123 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1/2 × Interventional × COVID-19 × Clear all
NCT04565665 2026-05-20

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
65 enrolled
Other hematologic neoplasm

COVID-19, Hematologic Neoplasms

NCT05303376 2023-09-13

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

Immune Biosolutions Inc

Phase 1/2 Completed
123 enrolled
Lymphoid

COVID-19, Lymphoma, Follicular, Respiratory Aspiration

NCT05273541 2022-04-18

Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer

Beijing 302 Hospital

Phase 1/2 Unknown
100 enrolled

COVID-19

NCT04834089 2021-04-08

SOROCOV

Butantan Institute

Phase 1/2 Unknown
618 enrolled
Genitourinary

COVID-19, Cardiovascular Diseases, Diabetes Mellitus, Kidney Diseases, Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡